- Areas of Interest
- Techniques
- Systems
- Products & Services
- Informatics
- Science & Education
- Company
- Support
Cutting-edge clinical cancer research solutions from Illumina deliver the accurate information your lab needs to improve the quality of your reporting and optimize—and even personalize—care. Rapidly analyze expert-defined genes and mutation hotspots to find actionable variants in any type of cancer, including solid tumors and hematological malignancies.
Our complete, seamless workflow solutions for translational cancer research include both fixed and customizable cancer panels and a comprehensive range of systems that can be scaled to meet your needs. Our multi-analyte approach enables you to get thorough information efficiently and cost-effectively, even from small specimens. In addition, these integrated solutions include data analysis and reporting capabilities to help you communicate significant findings effectively.
Dr. Rossi highlights the value of NGS for oncology, including the cost-effective analysis of multiple genes in a single test.
See how the latest advances in genomic technologies can help to identify important mutations in cancer.
Molecular profiling is critical for characterizing somatic mutations in cancer and can help to identify important biomarkers. Next-generation sequencing (NGS) is becoming more widely adopted as a valuable method for detecting somatic mutations in cancer.
Germline mutations that predispose individuals to cancer can be detected through various approaches, from genome-wide association studies to whole-genome and targeted sequencing.
Using cytogenomic analysis to understand the role chromosomal aberrations play in cancer is an integral part of current genomic medicine. Microarrays and NGS enable a complete view of chromosomal aberrations in cancer.
Illumina offers various products to support clinical cancer research. Our products feature integrated workflows that are easy to implement in standard lab procedures and simple analysis and reporting capabilities.
Learn more about Illumina technology and how it is being used in clinical cancer research. Access publications, videos, webinars, and other educational resources.
This targeted RNA sequencing panel is a cost-effective solution to detect gene fusions in multiple cancer types, regardless of origin.
Compare Targeted Panels for Cancer ResearchNGS that fits your benchtop and your budget. Perform accurate tumor profiling in your own lab, on your own schedule.
View All Benchtop SequencersMultifunctional, integrated MiniSeq software performs automatic onboard data analysis.
Find BaseSpace Apps for NGS Data Analysis
Discover the advantages of NGS over traditional hematological and solid tumor profiling methods.
Dr. Rachel Butler discusses why their lab adopted NGS and explains its advantages in molecular pathology for profiling solid tumor samples.
An introduction to NGS technology and applications for molecular pathologists.
Learn about current and future approaches to reimbursement coding and coverage for next generation sequencing assays.
Dr. Rossi explains the value of molecular testing, and helps newcomers to NGS explore targeted sequencing applications.
Dr. Jaime Platt provides insights into the potential of NGS integration into clinical research, with case examples of deep sequencing in tumor samples.
Discover demonstrated workflows for oncology applications.
Charles Mathews of Boston Healthcare discusses the reimbursement environment for Next Generation Sequencing.